ArticleRadiological physics and technology2026
Estimation of organ and effective doses in High-Resolution Cone-Beam Computed Tomography (HR-CBCT) during cerebral angiography.
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
High-resolution cone-beam computed tomography (HR-CBCT) during cerebral angiography raises concerns regarding high radiation exposure in exchange for high spatial resolution, but detailed dose assessments are lacking. This study aimed to accurately estimate organ dose (OD) and effective dose (ED) for HR-CBCT using the NCIRF Monte Carlo software, which incorporates projection-specific variations in X-ray output, and to derive dose conversion coefficients for clinical application. Four sites prone to cerebral aneurysms were scanned using a phantom, and exposure parameters were recorded for each projection angle. OD and ED were calculated using NCIRF. Simulation accuracy was validated by comparing lens doses measured with radiophotoluminescence glass dosimeters, and the results were compared with a conventional method that ignores projection-specific dose variations. The maximum brain OD was 46.2 mGy for males and 61.7 mGy for females. ED ranged from 0.70 to 0.89 mSv for males and 0.86-1.11 mSv for females. The relative difference between simulated and measured lens doses was less than 6.0%, demonstrating good agreement. The proposed method reduced lens dose error by approximately 20% compared to the conventional method. Conversion coefficients were calculated for each site and sex to estimate OD and ED from the air kerma-area product. This study demonstrated that dynamic Monte Carlo simulation incorporating projection-specific exposure variations can provide highly accurate dose estimations for HR-CBCT. The derived conversion coefficients offer a practical tool that can support optimization of patient radiation protection in clinical settings using similar equipment and protocols.
Indexed as
Identifiers
41171492What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.